35881299|t|Sarcococca saligna ameliorated D-galactose induced neurodegeneration through repression of neurodegenerative and oxidative stress biomarkers.
35881299|a|Sarcococca saligna is a valuable source of bioactive secondary metabolites exhibiting antioxidant, anti-inflammatory and acetylcholinesterase inhibitory activities. The study was intended to explore the therapeutic pursuits of S. saligna in amelioration of cognitive and motor dysfunctions induced by D-galactose and linked mechanistic pathways. Alzheimer's disease model was prepared by administration of D-galactose subcutaneous injection100 mg/kg and it was treated with rivastigmine (100 mg/kg, orally) and plant extract for 42 days. Cognitive and motor functions were evaluated by behavioral tasks and oxidative stress biomarkers. Level of acetylcholinesterase, reduced level of glutathione, protein and nitrite level, and brain neurotransmitters were analyzed in brain homogenate. The level of apoptosis regulator Bcl-2, Caspases 3 and heat shock protein HSP-70 in brain homogenates were analyzed by ELISA and colorimetric method, respectively. AChE, IL-1beta, TNF-alpha, IL-1alpha and beta secretase expressions were analyzed by RT-PCR. S. saligna dose dependently suppressed the neurodegenerative effects of D-galactose induced behavioral and biochemical impairments through modulation of antioxidant enzymes and acetylcholinesterase inhibition. S. saligna markedly (P < 0.05) ameliorated the level of brain neurotransmitters, Bcl-2, HSP-70 and Caspases-3 level. S. saligna at 500-1000 mg/kg considerably recovered the mRNA expression of neurodegenerative and neuro-inflammatory biomarkers, also evident from histopathological analysis. These findings suggest that S. saligna could be applicable in cure of Alzheimer's disease.
35881299	0	18	Sarcococca saligna	Species	153583
35881299	31	42	D-galactose	Chemical	MESH:D005690
35881299	51	68	neurodegeneration	Disease	MESH:D019636
35881299	91	108	neurodegenerative	Disease	MESH:D019636
35881299	142	160	Sarcococca saligna	Species	153583
35881299	195	216	secondary metabolites	Chemical	-
35881299	246	258	inflammatory	Disease	MESH:D007249
35881299	263	283	acetylcholinesterase	Gene	43
35881299	369	379	S. saligna	Species	153583
35881299	399	431	cognitive and motor dysfunctions	Disease	MESH:D003072
35881299	443	454	D-galactose	Chemical	MESH:D005690
35881299	488	507	Alzheimer's disease	Disease	MESH:D000544
35881299	548	559	D-galactose	Chemical	MESH:D005690
35881299	616	628	rivastigmine	Chemical	MESH:D000068836
35881299	787	807	acetylcholinesterase	Gene	43
35881299	826	837	glutathione	Chemical	MESH:D005978
35881299	851	858	nitrite	Chemical	MESH:D009573
35881299	962	967	Bcl-2	Gene	596
35881299	1003	1009	HSP-70	Gene	3308
35881299	1093	1097	AChE	Gene	43
35881299	1099	1107	IL-1beta	Gene	3553
35881299	1109	1118	TNF-alpha	Gene	7124
35881299	1120	1129	IL-1alpha	Gene	3552
35881299	1186	1196	S. saligna	Species	153583
35881299	1229	1246	neurodegenerative	Disease	MESH:D019636
35881299	1258	1269	D-galactose	Chemical	MESH:D005690
35881299	1278	1316	behavioral and biochemical impairments	Disease	MESH:D001523
35881299	1363	1383	acetylcholinesterase	Gene	43
35881299	1396	1406	S. saligna	Species	153583
35881299	1477	1482	Bcl-2	Gene	596
35881299	1484	1490	HSP-70	Gene	3308
35881299	1513	1523	S. saligna	Species	153583
35881299	1588	1605	neurodegenerative	Disease	MESH:D019636
35881299	1610	1628	neuro-inflammatory	Disease	MESH:C536203
35881299	1715	1725	S. saligna	Species	153583
35881299	1757	1776	Alzheimer's disease	Disease	MESH:D000544
35881299	Negative_Correlation	MESH:D000068836	MESH:D000544
35881299	Positive_Correlation	MESH:D005690	MESH:D001523
35881299	Positive_Correlation	MESH:D005690	MESH:D000544
35881299	Positive_Correlation	MESH:D005690	MESH:D019636
35881299	Association	MESH:D005690	43
35881299	Association	MESH:D001523	43
35881299	Association	MESH:D019636	43
35881299	Positive_Correlation	MESH:D005690	MESH:D003072

